Meditati
- Biotech or pharma, therapeutic R&D
Meditati strives to heal the world of addiction. Our team of leaders in drug discovery, AI, chemistry, and mental health disorders leverage a proprietary platform that exploits polypharmacology in the brain to develop treatments for previously intractable indications. Our flagship program is a non-opioid agonist therapy for opioid use disorder that targets multiple mechanisms underpinning drug reward, craving, and withdrawal. This multifaceted mechanism of action promises to overcome the limitations of single-target therapies that are particularly ineffective for complex disorders like addiction. Meditati is currently fundraising to further characterize and optimize its assets which have shown efficacy in vivo for treating opioid use disorder.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}